Pro-inflammatory cytokines and adhesion molecules

Pro-inflammatory cytokines and adhesion molecules represent a diverse group of proteins that orchestrate the body's inflammatory response and immune cell trafficking. Pro-inflammatory cytokines, such as Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), are signaling proteins secreted by immune cells to promote inflammation and coordinate the host defense against pathogens (StatPearls, 2023). Adhesion molecules, including Selectins, Integrins, and members of the Immunoglobulin superfamily like ICAM-1 and VCAM-1, are expressed on the surface of leukocytes and endothelial cells to facilitate the recruitment and migration of immune cells into tissues (NCBI, 2021). Dysregulation of these molecules is central to the pathogenesis of various conditions, including rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis (PubMed, 2022). Pharmacological intervention typically involves the use of monoclonal antibodies or small molecule inhibitors to block specific cytokines or their receptors, or to prevent the interaction between adhesion molecules and their ligands, thereby dampening the inflammatory cascade (Nature Reviews Drug Discovery, 2020).

Other names

Inflammatory mediatorsCell adhesion molecules (CAMs)Cytokines and CAMsPro-inflammatory mediators

Neutralization of pro-inflammatory cytokines, blockade of cytokine receptors, and inhibition of leukocyte-endothelial cell adhesion through binding to integrins or selectins.